Inactivator of O6-methylguanine-DNA methyltransferase
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Lomeguatrib

Item No. 11732

Technical Information
Formal Name
6-[(4-bromo-2-thienyl)methoxy]-9H-purin-2-amine
CAS Number
192441-08-0
Synonyms
  • PaTrin 2
Molecular Formula
C10H8BrN5OS
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 10 mg/mlDMSO: 5 mg/ml
λmax
239, 284 nm
SMILES
BrC1=CSC(COC2=NC(N)=NC3=C2NC=N3)=C1
InChi Code
InChI=1S/C10H8BrN5OS/c11-5-1-6(18-3-5)2-17-9-7-8(14-4-13-7)15-10(12)16-9/h1,3-4H,2H2,(H3,12,13,14,15,16)
InChi Key
JUJPKFNFCWJBCX-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Lomeguatrib is a modified quanine base which acts as a pseudosubstrate inactivator of MGMT (IC50 = ~3 nM).1,2 A non-toxic compound, lomeguatrib completely inactivates MGMT in human prostate and colorectal tumors when given as a single 120 mg oral dose and in primary central nervous system cancers at 160 mg.3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Clemons, M., Kelly, J., Watson, A.J., et alO6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts. Br. J. Cancer 93(10), 1152-1156 (2005).

    2. McMurry, T.B.H. MGMT inhibitors-the Trinity College-Paterson Institute experience, a chemist’s perception. DNA Repair 6(8), 1161-1169 (2007).

    3. Ranson, M., Middleton, M.R., Bridgewater, J., et alLomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: Phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin. Cancer Res. 12(5), 1577-1584 (2006).

    4. Watson, A.J., Sabharwal, A., Thorncroft, M., et alTumor O6-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib. Clin. Cancer Res. 16(2), 743-749 (2010).